Last updated on February 2015

Safety and Pharmacokinetic Characteristics of DKF-313


Brief description of study

This is a randomized, open-label, single-dose, 2-treatment, 2-way, 2-period crossover study to evaluate the safety and the pharmacokinetic characteristics of DKF-313 (dutasteride and tadalafil) in healthy male volunteers.

Detailed Study Description

This study is conducted to evaluate the pharmacokinetics of DKF-313 (dutasteride and tadalafil) comparing with the concomitant administration of AVODART and CIALIS in healthy male volunteers.

Clinical Study Identifier: NCT02352311

Contact Investigators or Research Sites near you

Start Over

Min-Gul Kim, M.D.

Chonbuk National University Hospital
Jeonju, Korea, Republic of
  Connect »